Showing results (181-190 of 467) with videos related to

Sort By:
Pageof 47
Mucosal Immunology|May 11, 2021
Bidirectional crosstalk between eosinophils and esophageal epithelial cells regulates inflammatory and remodeling processesJulia L M Dunn, Julie M Caldwell, Adina Ballaban, et al.
The Journal of Allergy and Clinical Immunology|October 9, 2025
Cendakimab (anti-IL-13) administration improves esophageal gene expression in eosinophilic esophagitisJulie M Caldwell, Adina Y Ballaban, Jie Li, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2015
Value of an Additional Review for Eosinophil Quantification in Esophageal BiopsiesEmily M Stucke, Katherine E Clarridge, Margaret H Collins, et al.
Science Signaling|December 22, 2016
Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophilsOdile Malbec, Lydie Cassard, Marcello Albanesi, et al.
Arthritis and Rheumatism|July 28, 2010
C5a receptor enables participation of mast cells in immune complex arthritis independently of Fcγ receptor modulationPeter A Nigrovic, Odile Malbec, Bao Lu, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2016
Resolving the etiology of atopic disorders by using genetic analysis of racial ancestryJayanta Gupta, Elisabet Johansson, Jonathan A Bernstein, et al.
American Journal of Respiratory Cell and Molecular Biology|April 19, 2003
Trefoil factor-2 is an allergen-induced gene regulated by Th2 cytokines and STAT6 in the lungNikolaos M Nikolaidis, Nives Zimmermann, Nina E King, et al.
The Journal of Biological Chemistry|December 26, 2001
Enterocyte expression of the eotaxin and interleukin-5 transgenes induces compartmentalized dysregulation of eosinophil traffickingAnil Mishra, Simon P Hogan, Eric B Brandt, et al.
Journal of Patient-Reported Outcomes|January 8, 2025
Patient experience with eosinophilic esophagitis symptoms and impacts on daily life based on in-trial qualitative interviewsCalvin N Ho, Harald Fjällbrant, Evan S Dellon, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 14, 2022
Mepolizumab Reduces Hypereosinophilic Syndrome Flares Irrespective of Blood Eosinophil Count and Interleukin-5Marc E Rothenberg, Florence Roufosse, Stanislas Faguer, et al.
Pageof 47